Baumer S.A. (BVMF:BALM3)

Market Cap	205.63M +13.1%
Revenue (ttm)	212.37M +2.4%
Net Income	19.26M -37.9%
EPS	1.97 -37.9%
Shares Out	n/a
PE Ratio	10.67
Forward PE	n/a
Dividend	4.68 (18.00%)
Ex-Dividend Date	May 4, 2026

Volume	400
Open	26.00
Previous Close	26.00
Day's Range	26.00 - 26.00
52-Week Range	20.00 - 33.00
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Baumer

Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring. It also provides life science equipment compr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1952
• Employees: 306
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BALM3

Financial Performance

In 2025, Baumer's revenue was 213.73 million, an increase of 9.95% compared to the previous year's 194.39 million. Earnings were 18.08 million, a decrease of -42.81%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 20, 2026

Data Sources Report a data error